These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21960668)

  • 1. Pharmacokinetics, pharmacodynamics, and safety of ticagrelor in volunteers with severe renal impairment.
    Butler K; Teng R
    J Clin Pharmacol; 2012 Sep; 52(9):1388-98. PubMed ID: 21960668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics, pharmacodynamics, and safety of ticagrelor in volunteers with mild hepatic impairment.
    Butler K; Teng R
    J Clin Pharmacol; 2011 Jul; 51(7):978-87. PubMed ID: 20926753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of significant food effect on the pharmacokinetics of ticagrelor in healthy volunteers.
    Teng R; Mitchell PD; Butler K
    J Clin Pharm Ther; 2012 Aug; 37(4):464-8. PubMed ID: 21967645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of ticagrelor in subjects on hemodialysis and subjects with normal renal function.
    Teng R; Muldowney S; Zhao Y; Berg JK; Lu J; Khan ND
    Eur J Clin Pharmacol; 2018 Sep; 74(9):1141-1148. PubMed ID: 29850937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of clinically significant pharmacological interactions between ticagrelor and enoxaparin or unfractionated heparin in healthy subjects.
    Teng R; Butler K
    J Clin Pharm Ther; 2012 Dec; 37(6):704-11. PubMed ID: 22747575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics, pharmacodynamics, tolerability and safety of single ascending doses of ticagrelor, a reversibly binding oral P2Y(12) receptor antagonist, in healthy subjects.
    Teng R; Butler K
    Eur J Clin Pharmacol; 2010 May; 66(5):487-96. PubMed ID: 20091161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of ticagrelor and AR-C124910XX in patients with prior myocardial infarction
.
    Röshammar D; Bergstrand M; Andersson T; Storey RF; Hamrén B
    Int J Clin Pharmacol Ther; 2017 May; 55(5):416-424. PubMed ID: 28139972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of ticagrelor in patients with stable coronary artery disease: results from the ONSET-OFFSET and RESPOND studies.
    Husted SE; Storey RF; Bliden K; Tantry US; Høimark L; Butler K; Wei C; Teng R; Gurbel PA
    Clin Pharmacokinet; 2012 Jun; 51(6):397-409. PubMed ID: 22515556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics, pharmacodynamics, and tolerability of single and multiple doses of ticagrelor in Japanese and Caucasian volunteers.
    Teng R; Butler K
    Int J Clin Pharmacol Ther; 2014 Jun; 52(6):478-91. PubMed ID: 24755129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population pharmacokinetics and pharmacodynamics of ticagrelor and AR-C124910XX in Chinese healthy male subjects.
    Liu S; Xue L; Shi X; Sun Z; Zhu Z; Zhang X; Tian X
    Eur J Clin Pharmacol; 2018 Jun; 74(6):745-754. PubMed ID: 29442148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ticagrelor pharmacokinetics and pharmacodynamics in patients with NSTEMI after a 180-mg loading dose.
    Holm M; Tornvall P; Westerberg J; Rihan Hye S; van der Linden J
    Platelets; 2017 Nov; 28(7):706-711. PubMed ID: 28150519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and tolerability of single and multiple doses of ticagrelor in healthy Chinese subjects: an open-label, sequential, two-cohort, single-centre study.
    Li H; Butler K; Yang L; Yang Z; Teng R
    Clin Drug Investig; 2012 Feb; 32(2):87-97. PubMed ID: 22168538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of rifampicin on the pharmacokinetics and pharmacodynamics of ticagrelor in healthy subjects.
    Teng R; Mitchell P; Butler K
    Eur J Clin Pharmacol; 2013 Apr; 69(4):877-83. PubMed ID: 23093043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamics, pharmacokinetics, and safety of ticagrelor in Chinese patients with stable coronary artery disease.
    Li H; Guo J; Carlson GF; Teng R
    Br J Clin Pharmacol; 2016 Aug; 82(2):352-61. PubMed ID: 27038001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of desmopressin on bleeding time and platelet aggregation in healthy volunteers administered ticagrelor.
    Teng R; Mitchell PD; Butler K
    J Clin Pharm Ther; 2014 Apr; 39(2):186-91. PubMed ID: 24444280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients with Acute Myocardial Infarction (IMPRESSION): study protocol for a randomized controlled trial.
    Kubica J; Adamski P; Ostrowska M; Koziński M; Obońska K; Laskowska E; Obońska E; Grześk G; Winiarski P; Paciorek P
    Trials; 2015 Apr; 16():198. PubMed ID: 25925591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population Pharmacokinetics/Pharmacodynamics of Ticagrelor in Children with Sickle Cell Disease.
    Amilon C; Niazi M; Berggren A; Åstrand M; Hamrén B
    Clin Pharmacokinet; 2019 Oct; 58(10):1295-1307. PubMed ID: 30972696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the pharmacokinetic interaction between ticagrelor and tolbutamide, a cytochrome P450 2C9 substrate, in healthy volunteers.
    Teng R; Mitchell P; Butler K
    Int J Clin Pharmacol Ther; 2013 Apr; 51(4):305-12. PubMed ID: 23380426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of age and gender on pharmacokinetics and pharmacodynamics of a single ticagrelor dose in healthy individuals.
    Teng R; Mitchell P; Butler K
    Eur J Clin Pharmacol; 2012 Aug; 68(8):1175-82. PubMed ID: 22367426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of ticagrelor in the management of acute coronary syndromes.
    Burgess S; Mallard TA; Juergens CP
    Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1315-25. PubMed ID: 22924796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.